Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Estonia

Coordination and Support Action · Running

DROPLETFACTORY Dropletfactory: Fast, Accessible Droplet-assisted Design of Novel Cell Factories

Coordinator
CogniFlow OU, Estonia
Runs
1 July 2026 to 30 June 2028
Status
Running
EU funding
€424k
Total cost
—
Partners
1 organisations in 1 countries
Type
Coordination and Support Action
Grant agreement
101310083

What the project is doing

In the project's own words, from its summary on CORDIS.

Biomanufacturing - the backbone of Europe’s sustainable bioeconomy - is slowed by the long, resource-intensive process of cell factory design. Developing microbial strains for food additives, biomedicines, enzymes or bio-based materials takes months, as most biolabs still rely on manual or robotic plate assays with limited throughput, high reagent use and labour cost. Droplet microfluidics can accelerate these workflows by compartmentalising reactions into millions of pico- to nanolitre droplets for massively parallel screening.

However, existing droplet-assisted systems are expensive (>€250k), energy-intensive, and difficult to customise, limiting adoption by SMEs, startups and academic labs. DROPLETFACTORY by CogniFlow OÜ addresses these barriers with a modular, flexible and transparent droplet-assisted cell factory design automation platform. It delivers 1000x higher throughput and up to 10x lower energy use than plate assays, while being 2–5x more affordable than commercial droplet platforms.

The system encapsulates, incubates, reads and sorts cell variants at up to 1000 Hz, with each droplet acting as a miniature bioreactor. Built on the CogniFlow® hardware-software platform, it integrates pumps, optical readout with edge-AI, microfluidic chip interfaces and intelligent control into a compact suitcase-size device tailored for SME labs. The project will integrate the current functional prototype into a unified system, add usability and performance optimisations to meet end-user targets, and validate the platform through customer-site testing.

In parallel, it will validate the business model, strengthen IP protection, complete the team and increase investment readiness to enable market entry and scaling. By shortening the strain-engineering cycle and lowering adoption barriers, DROPLETFACTORY will support Europe’s shift toward sustainable, energy-efficient and digitally enabled biomanufacturing.

Who is involved

OrganisationCityCountryRole
CogniFlow OUTallinnEstoniaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI